The upcoming 2024 PQA Annual Meeting's poster session will showcase 23 quality improvement and research projects. Sponsored by Pharmacy Quality Solutions, this session offers authors a platform to exhibit their work and enables attendees to engage in insightful discussions about healthcare quality.

The posters complement the meeting's array of educational programming, which includes four general sessions, 12 breakout sessions, a PQA and IHI continuing education seminar and a special pre-meeting half-day workshop. The breakout sessions, PQA/IHI seminar and half-day workshop are ACPE accredited for pharmacist continuing education.

This year’s poster session takes place on day two of the meeting, Wednesday, May 15, from 4:45-6:00 p.m., as part of the networking reception.

PQA conference posters provide comprehensive information about the study's objectives, methodology, and outcomes. The collaborative spirit at PQA is exceptional and a key factor in the organization's effectiveness. PQA's extensive membership and widespread influence in all aspects of medication use create an environment that fosters inclusivity and innovation.

This event offers an excellent opportunity to connect with pioneers and emerging leaders in medication use quality. In addition to completed projects, there will also be a student and fellow section to include works in progress.

With that in mind, here’s what will be presented in our poster session and the poster presenter for each project:

1. Development and Implementation of Collaborative Pharmacy Practice Agreements in an Integrated Health System Specialty Pharmacy: A Qualitative Analysis (Chelsea Renfro, PharmD)
2. Development and Implementation of Real-Time Dashboards for Specialty Pharmacy Clinical Outcome Measures (Shreevidya Periyasamy, MSHIA)
3. Effects of Part D Senior Savings Model on Healthcare Costs among the Medicare Population (Chi Chun Steve Tsang, PhD)
4. Effects of Part D Senior Savings Model on Racial and Ethnic Disparities in Healthcare Costs (Xiangjun Zhang) 
5. Evaluating Sodium Glucose Cotransporter-2 Inhibitor and Glucagon-Like Peptide-1 Receptor Agonist Use in Type 2 Diabetes or Chronic Kidney Disease (Rainier Ragasa, PharmD)
6. Evaluation of a Social Determinants of Health Screening and Intervention Framework within an Integrated Health System Specialty Pharmacy Care Model (Andrea Idusuyi, PharmD, CSP, AAHIVP)
7. Expanding Vaccination Access in Underserved Communities Across Maryland through a Collaborative Approach (Barbara Zarowitz, PharmD, MSW)
8. Focusing on New Prescriptions to Reduce Benzodiazepines in Older Adults (Stephanie Yoo, PharmD)
9. GLP-1 Medication Adherence (Joyce Chen, MS)
10. Health System Specialty Pharmacy: Ensuring Continuity of Care During Provider Transitions (Suprina Patel)
    
11. Impact of Clinical Dashboards for Data Capture and Reporting Across Health System Specialty Pharmacies (Kristin Darin, PharmD, BCPS)
12. Impact of Community Pharmacy Services on COVID-19 Vaccine Gap Closures in Medicaid Members (Stephanie McGrath, PharmD)
13. Impact of Point-of-Sale Duplicate Therapy Safety Alert on Concomitant DPP-4 Inhibitor and GLP-1 Agonist Use (Lauren Carroll, PharmD, BCACP)
14. Implementation of a Flowsheet to Track Patients with Inflammatory Bowel disease Initiating a Biologic with Complex Dosing Regimens (Jessica Fann, PharmD)
15. Implementation of an Ambulatory Clinical Pharmacist-Led Obesity Care program Within an Integrated Health-System Specialty Pharmacy (Rachel Quinn, PharmD, BCACP, AE-C)
16. Implementation of Behavioral Health Programs in Community Pharmacies: Lessons Learned (Melanie Livet, PhD)
17. Maximizing Cost Savings: The Impact of Specialty Pharmacist Interventions at a Community Oncology Center  (Casey Fitzpatrick, PharmD, BCPS)
18. Pharmacist-Led Adherence Interventions Explored in a Systematic Review for Future Cost-Benefit Insight (Bita Farrokhroo, PharmD)
19. Pharmacist-Mentored Implementation Collaborative: Opioid, Antimicrobial and High-Risk Medications Stewardship Program (Tosin David, PharmD)
20. Screening and Referral Programs for Diabetes and Cardiovascular Disease: Can Community Pharmacists Serve as Care Extenders? (Jon Easter, BSPharm)
21. Shaping Psychiatric Pharmacy Through Stewardship and Standardized Outcomes (Chelsea Di Polito, PharmD, BCPP)
22. Specialty Pharmacists Intervention to Improve Appeal Approval Rates for Specialty Medications within Medically-Integrated Dispensing Clinics (Jessica Fiant, PharmD, CSP)
23. The Impact of a Community Pharmacist Referral on the Completion of Annual Wellness Visits (Cody Beldon, PharmD)
    

We hope you’ll join us at the 2024 PQA Annual Meeting to learn, network, and engage. For the posters, we’ll present awards for the top posters, including an award for best student poster.